Decentralized Oncology Trials: Interview with Dr. Crystal S. Denlinger, CSO at NCCN
XTalks
APRIL 10, 2023
The adoption of decentralized clinical trial (DCT) approaches has increased exponentially. Tools such as electronic consent, telehealth appointments and wearable devices have enabled investigators to contact trial participants virtually. What are some barriers to adopting DCT methods in oncology trials?
Let's personalize your content